Docetaxel/gemcitabine administered every other week as first-line treatment for metastatic breast cancer: Final results of a phase II trial

1. Pelegrí, A.
2. Calvo, L.
3. Antón, A.
4. Mayordomo, J.I.
5. Florián, J.
6. Vázquez, S.
7. Arcusa, A.
8. Martín-Richard, M.
9. Bayo, J.L.
10. Carrasco, E.
11. Virizuela, J.